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Non‑communicable diseases 
deaths attributable to high body 
mass index in Chile
Ricardo Riquelme1,2, Leandro F. M. Rezende3, Juan Guzmán‑Habinger1,4, Javiera L. Chávez5, 
Carlos Celis‑Morales6,7,8, Catterina Ferreccio9 & Gerson Ferrari10*
We estimated the proportion and number of deaths from non‑communicable diseases (NCD) 
attributable to high body mass index (BMI) in Chile in 2018. We used data from 5927 adults from 
a 2016–2017 Chilean National Health Survey to describe the distribution of BMI. We obtained the 
number of deaths from NCD from the Ministry of Health. Relative risks (RR) and 95% confidence 
intervals per 5 units higher BMI for cardiovascular disease, cancer, and respiratory disease were 
retrieved from the Global BMI Mortality Collaboration meta‑analyses. The prevalences of overweight 
and obesity were 38.9% and 39.1%, respectively. We estimated that reducing population‑wide BMI to 
a theoretical minimum risk exposure level (mean BMI: 22.0 kg/m2; standard deviation: 1) could prevent 
approximately 21,977 deaths per year (95%CI 13,981–29,928). These deaths represented about 31.6% 
of major NCD deaths (20.1–43.1) and 20.4% of all deaths (12.9–27.7) that occurred in 2018. Most of 
these preventable deaths were from cardiovascular diseases (11,474 deaths; 95% CI 7302–15,621), 
followed by cancer (5597 deaths; 95% CI 3560–7622) and respiratory disease (4906 deaths; 95% CI 
3119–6684). A substantial burden of NCD deaths was attributable to high BMI in Chile. Policies and 
population‑wide interventions are needed to reduce the burden of NCD due to high BMI in Chile.
Abbreviations
BMI  Body mass index
CI  Confidence intervals
NHS  National Health Survey
ICD  International Classification of Diseases
NCDs  Non-communicable diseases
PAF  Population attributable fraction
RR  Risk relative
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Compelling epidemiological and clinical evidence suggests that overweight and obesity increase the risk of several 
non-communicable diseases (NCD), including cardiovascular diseases, respiratory diseases, and several types of 
 cancer1–3. Globally, the number of deaths due to high body mass index (BMI) has substantially increased from, 
approximately, 2.2 million (women 1.2 million and men 1.0 million) in 1990 to 4.7 million (women 2.4 million 
and men 2.3 million) in  20174. In Latin America, deaths attributable to high BMI increased by 12.7% in women 
and 26.8% in men between 1990 to  20174.
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During the past three decades, Chile has experienced a fast economic growth and lifestyle  transition5,6. 
These lifestyles changes have led the Chilean population to have one of the highest prevalences of obesity and 
other cardiovascular risk factors within the Latin American countries. In Chile, the prevalence of overweight or 
obesity reached 78% in 2017, among which, approximately, 4 million inhabitants (≥ 15 years) were living with 
 obesity7. High prevalence of overweight and obesity may lead to a substantial increase in the burden of  NCD8–10. 
For instance, it has been estimated that 8.7% (4394 out of 50,320 cases) of all cancer cases diagnosed in Chile in 
2018 were attributable to high  BMI11. Other studies have also estimated that obesity reduces life expectancy by 
3.5  years9. However, national and subnational quantification of the burden of NCDs attributable to high BMI in 
Chile is unavailable. This quantitative information is timely and important to inform the development of inter-
ventions and public health policies aimed at counteracting the burden generated by high BMI.
In this study, we sought to estimate the proportion and number of deaths from NCD attributable to high 
BMI, using national and subnational representative data from Chile.
Material and methods
Study design. We obtained data from the National Health Survey of Chile 2016–2017 (National Health 
Survey—NHS). Briefly, the NHS was a cross-sectional household survey that included 6233 participants aged 
15 years and over. NHS sampling method used a stratified and multistage selection of participants. Thirty strata 
were considered, which represented urban and rural areas of 15 geographical regions. In the multistage sam-
pling, the selection was based on counties as the primary sampling unit, households as the secondary sampling 
unit, and, finally, one participant from selected households as the tertiary sampling unit. Sampling weights from 
the survey accounted for differences in selection probability and non-response rates, and the post-stratification 
adjustment allowed to expand the sample to the estimated population in Chile. Data collection was carried out 
between August 2016 and March 2017. One participant per household was randomly selected using a Kish com-
putational algorithm and the response rate was 67%. The NHS 2016–2017 was funded by the Chilean Ministry of 
Health and approved by the Research Ethics Committee of the Faculty of Medicine of the Pontificia Universidad 
Católica de Chile (No. 16–019), and was performed in accordance with relevant guidelines and regulations. All 
participants gave their written consent before participating. Details on NHS 2016–2017 are available  elsewhere7. 
In this study, we retrieved data from 5927 adults aged 20 to 96 years, who had comprehensive data available to 
measure weight and height.
The BMI was calculated as weight (in kg) by the square of height (in meters)5,6. Height was measured with a 
portable stadiometer with accuracy to the nearest 0.1 cm) and weight was measured with a digital scale (Tanita 
HD313) with an accuracy of 0.1 kg. Weight measurements were taken barefoot and the participants wore light 
 clothing7. We estimated prevalences of underweight (≤ 18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight 
(25.0–29.9 kg/m2) and obesity (≥ 30.0 kg/m2)7. We also calculated the mean and standard deviation of BMI. The 
NHS complex sample design was considered for calculating the prevalences of BMI categories and mean and 
standard deviation of BMI.
Deaths from non‑communicable diseases and relative risks. We obtained the number of deaths 
in Chile in 2018 by sex and region (Arica/Parinacota, Tarapacá, Antofagasta, Atacama, Coquimbo, Valparaíso, 
Metropolitan, Libertador General Bernardo O’Higgins, Maule, Bío Bío, La Araucanía, Los Ríos, Los Lagos, 
Aysén, and Magallanes/Antartica), from the Official Deaths Statistics of the Ministry of  Health12. We retrieved 
number of deaths from cardiovascular disease (International Classification of Diseases, Tenth Revision [ICD-10] 
codes I00-I99 and R96)13, respiratory disease (ICD-10 codes J00-J99), and cancer (ICD-10 codes C00-C97 and 
D00-D48)12.
Relative risks (RR) and 95% confidence intervals (CI) per 5 units of BMI for all-cause, cardiovascular dis-
ease, respiratory disease, and cancer mortality were retrieved from the Global BMI Mortality Collaboration 
meta-analyses14.
Statistical analysis. Potential impact fraction (PIF)15,16 for each NCD by sex was calculated using the fol-
lowing equation:
where P is the mean and standard deviation (SD) of BMI in Chile in 2017, P* is the mean and standard deviation 
of BMI in the counterfactual scenarios (described below), RR is the relative risk per 1 kg/m2 increase, and dx indi-
cates the integration of RR according to BMI units (log-logit function was used to represent the dose–response 
relation between BMI and  NCD17,18). We considered two counterfactual scenarios of BMI distribution:
i) Theoretical minimum risk exposure level: mean BMI of 22 kg/m2 and 1 sd (the midpoint of the eutrophic 
(normal weight) category), resulting in the proportion of deaths from each disease attributable to high BMI 
(aka population attributable fraction).
ii) Realistic reduction in the BMI distribution: Alternative BMI scenario based on the BMI distribution in 
men (mean BMI of 27.1 kg/m2 and 4.2 sd) and women (mean BMI of 28.3 kg/m2 and 5.5 sd) in Chile in 
2003/2004.
To obtain the number of deaths from NCD attributable to high BMI, we applied PIF for cardiovascular dis-
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number of attributable deaths and divided it by total number of major NCDs (cardiovascular disease, cancer, 
and respiratory disease) and total number of deaths (all-cause mortality). We applied a simulation method in 
which repeated draws from PIF and the number of attributable/preventable deaths were generated considering 
the variability of BMI data. The simulation process was repeated 5000 times for each sex to calculate the mean 
and 95% confidence intervals (CI) of PIF and the number of attributable/preventable deaths.
Ethics approval and consent to participate. The protocol of each wave of the NHS 2016–2017 was 
approved by the Ethics Committee of the Pontificia Universidad Católica de Chile (Pontifical Catholic University 
of Chile—(No. 16–019), institution in charge of the studies. Participants signed an informed consent to take part 
in the study.
Results
A total 5927 participants (2218 [37.4%] men) were included in the study. The mean age was 51.1 (SD: 18.0) years; 
50.7 (SD: 18.0) in men and 51.3 (SD: 17.9) in women. The mean population BMI was 29.2 kg/m2 (SD: 5.5 kg/m2) 
with 28.4 kg/m2 (SD: 4.8 kg/m2) for men and 29.6 kg/m2 (SD: 5.8 kg/m2) for women (Fig. 1).
Overall, the prevalence of overweight (BMI 25.0–29.9 kg/m2) and obesity (BMI (≥ 30.0 kg/m2) were 38.9% 
and 39.1%, respectively. In men, the prevalence of overweight was 44.4% and obesity 32.6%. In women, the 
respective prevalences were 35.9% and 42.8% (Table 1).
We estimated that reducing population-wide BMI to a theoretical minimum risk exposure level (mean BMI 
22 kg/m2 and standard deviation 1) could prevent 21,977 deaths (95% CI 13,981 to 29,928) from NCD in Chile. 
These deaths represented about 31.6% of major NCD deaths (95% CI 20.1 to 43.1) and 20.4% of all deaths 
(95% CI 12.9 to 27.7) that occurred in 2018. Most of these preventable deaths were from cardiovascular disease 
Figure 1.  Distribution of body mass index (kg/m2) in adults from Chile by sex, 2016–2017.
Table 1.  Prevalence of overweight or obesity (≥ 25 kg/m2) by region in Chile. 95%CI confidence interval 95%.
Regions
Prevalence of over weight or obesity and its 95% CI
Both Men Women
Chile (total) 78.0 (76.9; 79.2) 77.0 (75.2; 78.7) 78.6 (77.4; 80.1)
Arica/Parinacota 77.3 (72.2; 81.9) 78.5 (70.2; 86.5) 76.6 (70.4; 82.5)
Tarapacá 80.8 (75.9; 85.7) 81.0 (72.6; 89.3) 80.8 (74.7; 86.1)
Antofagasta 68.8 (62.9; 75.0) 64.4 (55.3; 74.0) 71.7 (64.3; 78.7)
Atacama 75.2 (69.8; 80.2) 73.6 (64.4; 81.5) 76.3 (69.7; 82.4)
Coquimbo 78.9 (74.1; 83.8) 79.3 (69.5; 87.5) 78.8 (72.8; 84.3)
Valparaíso 72.0 (68.1; 75.9) 68.7 (62.1; 74.9) 74.0 (69.3; 78.6)
Metropolitan 77.7 (74.6; 80.4) 78.6 (73.8; 83.2) 77.2 (73.2; 80.8)
Libertador General Bernardo O’Higgins 76.3 (70.9; 81.3) 78.0 (79.7; 85.5) 75.1 (68.4; 81.6)
Maule 79.5 (75.2; 83.8) 81.4 (73.3; 88.9) 78.7 (73.3; 83.4)
Bío Bío 82.4 (79.0; 85.6) 76.3 (70.6; 81.9) 86.1 (82.4; 89.6)
La Araucanía 83.1 (78.2; 87.6) 78.6 (69.6; 87.1) 85.5 (79.5; 91.0)
Los Ríos 80.7 (75.5; 85.5) 77.0 (67.5; 86.6) 82.1 (76.3; 87.3)
Los Lagos 82.2 (77.4; 86.7) 83.7 (76.0; 90.3) 81.4 (75.5; 87.1)
Aysén 78.9 (74.3; 83.8) 81.7 (73.6; 88.4) 77.1 (71.0; 83.3)
Magallanes/Antartica 78.5 (73.2; 83.5) 82.0 (74.2; 89.2) 76.4 (69.3; 83.0)
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(11,474 deaths; 95% CI 7302 to 15,621), followed by cancer (5597 deaths; 95% CI 3560 to 7622) and respiratory 
disease (4906 deaths; 95% CI 3119 to 6684) (Table 2). Reducing population-wide BMI in Chile to levels observed 
in 2003/2004 could prevent 2329 deaths (95% CI 1546 to 3093), representing 6% of deaths from major NCDs 
(95% CI 3.8 to 8.2) and 3.9 of all deaths (95% CI 2.5 to 5.2) in Chile in 2018 (Table 3). 
In men, the highest all-cause mortality PAF were found in the Magallanes/Antartica region (44.9%) followed 
by Los Lagos region (43.4%); in women, the highest all-cause mortality PAF was in Libertador B. O’Higgins 
region (41.6%) followed by Del Maule region (40.2%) (Fig. 2).
Discussion
In this study, we estimated the proportion and number of deaths from NCD attributable to high BMI using 
national representative data in Chile. We estimated that 21,977 deaths from NCD were attributable to high BMI, 
which represented about 31.6% of major NCD deaths and 20.4% of all deaths in 2018. Most of these preventable 
deaths were from cardiovascular disease, followed by cancer and respiratory disease. Regions with the highest 
burden of deaths attributable to high BMI were Los Lagos, Libertador B. O’Higgins and Maule.
Excess body weight is increasing and driving up its attributable burden throughout Chile, corroborating global 
findings for this specific risk  factor7. Our study shows that high BMI played an important role in the national 
burden of NCD, especially those related to cardiovascular diseases. Prior studies have shown a positive associa-
tion between excess body weight and mortality in four  continents14. The present study has extended this existing 
evidence and reported the mortality burden of major NCDs using national and subnational representative data 
from Chile. Our results are similar to those found for other  countries14,19. In Brazil, the decrease in BMI could 
prevent up to 65,721 deaths from NCDs. Approximately 25.3% of major NCD deaths and 14.9% of all deaths 
could be prevented each year in Brazil by reducing population-wide BMI to the theoretical minimum  risk14. 
In the United States, 280,000 deaths are attributed to excess body weight. Population attributable fractions for 
all-cause mortality from overweight or obesity were 19% in North  America14. Furthermore, more than 60% of 
overweight individuals live in low- and middle-income countries, and, in these settings, the impact of high BMI 
on morbidity and mortality has been  understudied20.
Major causes of death, including cardiovascular disease, and cancers are closely associated with high  BMI21. 
Among these leading causes, a clear majority were due to cardiovascular diseases. We estimated that 41.8% of 
Table 2.  Proportion and numbers of deaths from NCD attributable to high body mass index by sex and 
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Table 3.  Proportion and number of deaths from NCD that could be avoided if body mass index in Chile 
in 2018 was equal to body mass index in Chile in 2003/2004.
Outcomes
Both Men Women
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Figure 2.  Population attributable fraction of (A) cancer; (B) cardiovascular disease; (C) respiratory disease; (D) major non-
communicable disease; (E) all-cause mortality due to high body mass index in 15 Chilean geographical regions. Population 
attributable fraction indicate the proportion (%) of deaths attributable to cause-specific and all-causes of deaths. The size of the 
circle represents the absolute number of cause-specific and all-causes of deaths attributable to high body mass index. Figure 
was created from the R software (version 4.0.5: Copyright (C) 2020 The R Foundation for Statistical Computing Platform: 
x86_64-w64-mingw32/x64 (64-bit) Link: https:// www.r- proje ct. org/).
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cardiovascular diseases deaths were attributable to excess body weight in Chile. A previous study reported that 
overweight was associated with a shorter lifespan and significantly higher risk of cardiovascular diseases mor-
bidity and mortality compared with normal  BMI22. The Global Burden of Disease Study showed that 3.9% of 
global cancer cases were attributable to high  BMI23. Another study estimated that, globally, 3.6% of all new cancer 
cases in adults were attributable to high  BMI17. These findings provide insight into the underlying contribution 
of excess body weight to deaths from NCDs, indicating that reducing population-wide BMI may have a great 
contribution for the prevention of premature deaths from NCDs.
Worldwide, it has been estimated that 15% of deaths from all-causes are due to a high  BMI24. In United States 
the reported estimates ranged from 5 to 15% for all-cause  mortality25. In South American countries, a previous 
study has calculated that a high BMI is responsible for approximately 12.3% of all  deaths26. Worldwide, 4.7 mil-
lion deaths from NCD were associated with a high BMI, accounting for 17.7% of all causes of death in 2017. This 
represents a 118.8% increase since 1990, with a projection of 5.5 million deaths in  202521. Our findings of 20.3% 
of all-cause mortality due to high BMI is one of the largest reported in the literature so far. These results are likely 
due to the remarkably high prevalence of overweight and obesity in Chile (approximately 78%).
The association between high BMI and mortality has been widely reported in the  literature1–3. There are sev-
eral biological mechanisms through which high BMI increases the risk of  NCD27–29. High BMI causes chronic 
systemic inflammation and higher sympathetic activity, which can contribute to insulin resistance and hyperten-
sion,  respectively27, leading to endothelial dysfunction and  atherosclerosis30. Thus, its effect is primarily mediated 
through other intermediary risk factors, such as hypertension, hypercholesterolemia, and hyperglycemia, the 
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Our study suggests a high mortality burden of NCDs related to BMI, which may be useful to improve public 
awareness and support population-wide interventions and public health policies to reduce excess body weight in 
Chile. Public health policy and other relevant stakeholders should pay consideration to this issue and prioritize 
their agenda, designing and implementing effective policies. Evidence-based interventions should be aimed at 
empowering and educating individuals, making them aware of the potentially detrimental consequences of their 
higher levels of  adiposity31, and encouraging physical activity. New data and communication technologies could 
be exploited for the aim of both gathering BMI and other pertinent evidence and fostering changes, tracking 
variations over  time4.
In this study, we used measured BMI from a representative sample of Chilean adults to estimate the burden 
of deaths from NCD attributable to high BMI. However, our study has several limitations. Although BMI is a 
useful indicator of overall body fat, it does not distinguish between lean and fat  tissues32. However, it is unlikely 
that body fat measurements could be used extensively in clinical practice as BMI currently is due to the addi-
tional cost associated with this sort of measurement. Furthermore, we used RR estimates from a meta-analysis 
that included data from four continents but not from  Chile14. It is unknown if these RR estimates are applicable 
to Chileans. However, these reliable RR estimates included never-smokers who had no prevalent diseases and 
excluded the first five years of follow-up to reduce reverse  causality14. We applied the RR estimated for Chile’s 
general population, regardless of disease and smoking status. NHS is not carried out annually to compare preva-
lence for 2016–2017 and 2018. We assumed that the distribution of BMI in 2018 is similar to the one obtained 
in the ENS 2016/2017.
Conclusions
The prevalence of overweight and obesity is high (approximately 78%) in the Chilean population, with some 
variability across regions. Such high BMI conferred, approximately, 21,977 deaths from NCD per year in Chile, 
which represents about 31.6% of major deaths from NCD and 20.4% of all deaths in 2018. These results suggest 
the need for public health programs aimed at maintaining a healthy weight in order to tackle the NCD burden 
in Chile. Strong public health policies aimed to reduce obesogenic environments are needed to decrease obesity 
and its health burden in Chile.
Data availability
The datasets generated and/or analysed during the current study are available in the database repository of the 
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